{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:41:09Z","timestamp":1768408869234,"version":"3.49.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T00:00:00Z","timestamp":1518048000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD065862"],"award-info":[{"award-number":["HD065862"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["OD011107 and OD010962"],"award-info":[{"award-number":["OD011107 and OD010962"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2018.00021","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T04:33:35Z","timestamp":1518064415000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Fluoxetine Administration in Juvenile Monkeys: Implications for Pharmacotherapy in Children"],"prefix":"10.3389","volume":"6","author":[{"given":"Mari S.","family":"Golub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey E.","family":"Hogrefe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Sherwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph W.","family":"Turck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1007\/s00213-014-3537-y","article-title":"Fluoxetine: juvenile pharmacokinetics in a nonhuman primate model","volume":"231","author":"Golub","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e478","DOI":"10.1038\/tp.2014.116","article-title":"Identifying individual differences of fluoxetine response in juvenile rhesus monkeys by metabolite profiling","volume":"4","author":"He","year":"2014","journal-title":"Transl Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bone.2015.05.042","article-title":"Bone growth in juvenile rhesus monkeys is influenced by 5HTTLPR polymorphisms and interactions between 5HTTLPR polymorphisms and fluoxetine","volume":"79","author":"Golub","year":"2015","journal-title":"Bone"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ntt.2016.02.006","article-title":"Sleep disturbance as detected by actigraphy in pre-pubertal juvenile monkeys receiving therapeutic doses of fluoxetine","volume":"55","author":"Golub","year":"2016","journal-title":"Neurotoxicol Teratol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.neuropharm.2016.02.025","article-title":"Peer social interaction is facilitated in juvenile rhesus monkeys treated with fluoxetine","volume":"105","author":"Golub","year":"2016","journal-title":"Neuropharmacology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.euroneuro.2016.10.010","article-title":"Regulation of emotional response in juvenile monkeys treated with fluoxetine: MAOA interactions","volume":"26","author":"Golub","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.euroneuro.2016.03.017","article-title":"Peripheral fibroblast metabolic pathway alterations in juvenile rhesus monkeys undergoing long-term fluoxetine administration","volume":"26","author":"Su","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.dcn.2017.04.008","article-title":"Cognitive performance of juvenile monkeys after chronic fluoxetine treatment","volume":"26","author":"Golub","year":"2017","journal-title":"Dev Cogn Neurosci"},{"key":"B9","first-page":"67","article-title":"The effects of fluoxetine and buspirone on self-injurious and stereotypic behavior in adult male rhesus macaques","volume":"55","author":"Fontenot","year":"2005","journal-title":"Comp Med"},{"key":"B10","first-page":"176","article-title":"Dose-finding study of fluoxetine and venlafaxine for the treatment of self-injurious and stereotypic behavior in rhesus macaques (Macaca mulatta)","volume":"48","author":"Fontenot","year":"2009","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000329417","article-title":"Pharmacokinetics of fluoxetine in rhesus macaques following multiple routes of administration","volume":"88","author":"Sawyer","year":"2011","journal-title":"Pharmacology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1055\/s-0031-1291294","article-title":"Therapeutic drug monitoring of children and adolescents treated with fluoxetine","volume":"45","author":"Koelch","year":"2012","journal-title":"Pharmacopsychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1037\/a0036320","article-title":"Mind the gap: why many geneticists and psychological scientists have discrepant views about gene-environment interaction (GxE) research","volume":"69","author":"Duncan","year":"2014","journal-title":"Am Psychol"},{"key":"B14","volume-title":"Medical Review: Center for Drug Evaluation and Research: Application Number 18-936\/SE5-064","author":"Mosholder","year":"2002"},{"key":"B15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1089\/cap.2004.14.412","article-title":"Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents","volume":"14","author":"Nilsson","year":"2004","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/cap.2014.0076","article-title":"Acute and longer-term safety results from a pooled analysis of duloxetine studies for the treatment of children and adolescents with major depressive disorder","volume":"25","author":"Emslie","year":"2015","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B17","unstructured":"Prozac (Fluoxetine Hydrochloride) Capsules Label2017"},{"key":"B18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1177\/2045125313487548","article-title":"Possible mechanisms for the skeletal effects of antipsychotics in children and adolescents","volume":"3","author":"Calarge","year":"2013","journal-title":"Ther Adv Psychopharmacol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s40501-015-0034-9","article-title":"SSRI-induced activation syndrome in children and adolescents-what is next","volume":"2","author":"Amitai","year":"2015","journal-title":"Curr Treat Options Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1001\/archpsyc.63.3.332","article-title":"Suicidality in pediatric patients treated with antidepressant drugs","volume":"63","author":"Hammad","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/cap.1990.1.193","article-title":"Behavioral side effects of fluoxetine in children and adolescents","volume":"1","author":"Riddle","year":"1990","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.psychres.2014.11.070","article-title":"A pilot study of actigraphy as an objective measure of SSRI activation symptoms: results from a randomized placebo controlled psychopharmacological treatment study","volume":"225","author":"Bussing","year":"2015","journal-title":"Psychiatry Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/JCP.0000000000000564","article-title":"Raising the minimum effective dose of serotonin reuptake inhibitor antidepressants: adverse drug events","volume":"36","author":"Safer","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0893-133x(94)00075-b","article-title":"Fluoxetine and oculomotor activity during sleep in depressed patients","volume":"12","author":"Armitage","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/00004714-199706000-00004","article-title":"A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients","volume":"17","author":"Armitage","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1089\/cap.1992.2.259","article-title":"Fluoxetine in children and adolescents with mood disorders: a chart review of efficacy and adverse effects","volume":"2","author":"Jain","year":"1992","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/104454603322163862","article-title":"A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors","volume":"13","author":"Wilens","year":"2003","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0893-133X(97)00048-1","article-title":"The effect of fluoxetine on sleep EEG in childhood depression: a preliminary report","volume":"17","author":"Armitage","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/01.CHI.0000037049.04952.9F","article-title":"Fluoxetine for the treatment of childhood anxiety disorders","volume":"42","author":"Birmaher","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1097\/chi.0b013e318154bb57","article-title":"SET-C versus fluoxetine in the treatment of childhood social phobia","volume":"46","author":"Beidel","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/0269881106065102","article-title":"The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials","volume":"21","author":"Hedges","year":"2007","journal-title":"J Psychopharmacol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1176\/ajp.155.3.373","article-title":"Selective alteration of personality and social behavior by serotonergic intervention","volume":"155","author":"Knutson","year":"1998","journal-title":"Am J Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/026988110101500313","article-title":"Serotonergic involvement in the psychosocial dimension of personality","volume":"15","author":"Tse","year":"2001","journal-title":"J Psychopharmacol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00213-001-0926-9","article-title":"Difference in serotonergic and noradrenergic regulation of human social behaviours","volume":"159","author":"Tse","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s00213-002-1049-7","article-title":"Serotonergic intervention affects both social dominance and affiliative behaviour","volume":"161","author":"Tse","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/0269881103017002007","article-title":"Reboxetine promotes social bonding in healthy volunteers","volume":"17","author":"Tse","year":"2003","journal-title":"J Psychopharmacol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1055\/s-2006-948328","article-title":"Noradrenaline might enhance assertive human social behaviours: an investigation in a flatmate relationship","volume":"39","author":"Tse","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.euroneuro.2014.07.011","article-title":"Using a partner\u2019s facial emotion to elucidate social dominance motivation induced by an SSRI","volume":"24","author":"Tse","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1365-2125.1995.tb04468.x","article-title":"A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance","volume":"39","author":"Ramaekers","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/00004714-199806000-00006","article-title":"Venlafaxine\u2019s effects on healthy volunteers\u2019 driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens","volume":"18","author":"O\u2019Hanlon","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/026988110201600303","article-title":"Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man","volume":"16","author":"Schmitt","year":"2002","journal-title":"J Psychopharmacol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/0269881105048887","article-title":"Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment","volume":"19","author":"Riedel","year":"2005","journal-title":"J Psychopharmacol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/hup.923","article-title":"Sustained attention and serotonin: a pharmaco-fMRI study","volume":"23","author":"Wingen","year":"2008","journal-title":"Hum Psychopharmacol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/cap.2006.16.159","article-title":"Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents","volume":"16","author":"Safer","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/cap.2010.0152","article-title":"Age-grouped differences in adverse drug events from psychotropic medication","volume":"21","author":"Safer","year":"2011","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1089\/cap.2015.0034","article-title":"Adverse events in very young children prescribed psychotropic medications: preliminary findings from an acute clinical sample","volume":"25","author":"Lee","year":"2015","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00213-009-1597-1","article-title":"Short-term antidepressant treatment modulates amygdala response to happy faces","volume":"206","author":"Norbury","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"B48","doi-asserted-by":"crossref","first-page":"477","DOI":"10.31887\/DCNS.2015.17.4\/apringle","article-title":"The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment","volume":"17","author":"Pringle","year":"2015","journal-title":"Dialogues Clin Neurosci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1176\/appi.ajp.2011.11040615","article-title":"Brain activity in adolescent major depressive disorder before and after fluoxetine treatment","volume":"169","author":"Tao","year":"2012","journal-title":"Am J Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jad.2013.06.050","article-title":"Neural response to emotional stimuli associated with successful antidepressant treatment and behavioral activation","volume":"151","author":"Rizvi","year":"2013","journal-title":"J Affect Disord"},{"key":"B51","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.dcn.2013.08.005","article-title":"Emotional reactivity and its impact on neural circuitry for attention-emotion interaction in childhood and adolescence","volume":"8","author":"Perlman","year":"2014","journal-title":"Dev Cogn Neurosci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/01.pra.0000460619.10429.4c","article-title":"Use of antipsychotic medications in pediatric and young adult populations: future research needs","volume":"21","author":"Christian","year":"2015","journal-title":"J Psychiatr Pract"},{"key":"B53","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1176\/appi.ajp.2013.13020183","article-title":"Fluoxetine administered to juvenile monkeys: effects on the serotonin transporter and behavior","volume":"171","author":"Shrestha","year":"2014","journal-title":"Am J Psychiatry"},{"key":"B54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0306-4522(95)00051-J","article-title":"Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex","volume":"67","author":"Anderson","year":"1995","journal-title":"Neuroscience"},{"key":"B55","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0006-8993(00)02909-7","article-title":"Chronic fluoxetine administration to juvenile rats prevents age-associated dendritic spine proliferation in hippocampus","volume":"883","author":"Norrholm","year":"2000","journal-title":"Brain Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/j.1460-9568.2005.03968.x","article-title":"Short-term treatment with the antidepressant fluoxetine triggers pyramidal dendritic spine synapse formation in rat hippocampus","volume":"21","author":"Hajszan","year":"2005","journal-title":"Eur J Neurosci"},{"key":"B57","first-page":"162","article-title":"Neonatal exposure to fluoxetine and fluvoxamine alteres spine density in mouse hippocampal CA1 pyramidal neurons","volume":"4","author":"Zheng","year":"2011","journal-title":"Int J Clin Exp Pathol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/tpj.2014.12","article-title":"Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients","volume":"14","author":"Gasso","year":"2014","journal-title":"Pharmacogenomics J"},{"key":"B59","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11306-016-1094-6","article-title":"Metabolomics enables precision medicine: \u201ca white paper, community perspective\u201d","volume":"12","author":"Beger","year":"2016","journal-title":"Metabolomics"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1038\/tp.2011.56","article-title":"Metabolite profiling of antidepressant drug action reveals novel drug targets beyond monoamine elevation","volume":"1","author":"Webhofer","year":"2011","journal-title":"Transl Psychiatry"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1038\/tp.2014.119","article-title":"Time-dependent metabolomic profiling of ketamine drug action reveals hippocampal pathway alterations and biomarker candidates","volume":"4","author":"Weckmann","year":"2014","journal-title":"Transl Psychiatry"},{"key":"B62","doi-asserted-by":"publisher","first-page":"35317","DOI":"10.1038\/srep35317","article-title":"Purine and pyrimidine metabolism: convergent evidence on chronic antidepressant treatment response in mice and humans","volume":"6","author":"Park","year":"2016","journal-title":"Sci Rep"},{"key":"B63","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jpsychires.2013.09.017","article-title":"Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-naive first-episode schizophrenia patients","volume":"48","author":"Gasso","year":"2014","journal-title":"J Psychiatr Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e626","DOI":"10.1038\/tp.2015.122","article-title":"Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls","volume":"5","author":"Batalla","year":"2015","journal-title":"Transl Psychiatry"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1176\/appi.ajp.158.12.2048","article-title":"Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression","volume":"158","author":"Renshaw","year":"2001","journal-title":"Am J Psychiatry"},{"key":"B66","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.pneurobio.2011.08.006","article-title":"Purinergic signalling: from normal behaviour to pathological brain function","volume":"95","author":"Burnstock","year":"2011","journal-title":"Prog Neurobiol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2174\/1566524015666150330163724","article-title":"Purinergic signaling and energy homeostasis in psychiatric disorders","volume":"15","author":"Lindberg","year":"2015","journal-title":"Curr Mol Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fped.2018.00021\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T22:05:20Z","timestamp":1603836320000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fped.2018.00021\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,8]]},"references-count":67,"alternative-id":["10.3389\/fped.2018.00021"],"URL":"https:\/\/doi.org\/10.3389\/fped.2018.00021","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,8]]},"article-number":"21"}}